Latest News about AMGN
Recent news which mentions AMGN
Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy
January 10, 2022
Tickers
AMGN
From Benzinga
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
January 09, 2022
From Benzinga
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
From Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
From Benzinga
What Does This Label Expansion Mean for Amgen's Shareholders?
January 05, 2022
Tickers
AMGN
From Motley Fool
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
January 04, 2022
From Benzinga
Meet the 2022 Dogs of the Dow
January 04, 2022
From Motley Fool
From Motley Fool
Could This FDA Approval Create a Blockbuster Drug for AbbVie?
January 02, 2022
From Motley Fool
These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?
January 01, 2022
From Motley Fool
Could AstraZeneca Help You Retire a Millionaire?
January 01, 2022
From Motley Fool
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
From Benzinga
These are the best-performing S&P 500 and Nasdaq-100 stocks of 2021
December 30, 2021
From MarketWatch
From InvestorPlace
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
December 20, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
From Benzinga
These 2 Dividend ETFs Are a Retiree's Best Friend
December 17, 2021
From Motley Fool
Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?
December 15, 2021
From Motley Fool
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.